Clinical Trials Directory

Trials / Unknown

UnknownNCT04489615

Identification of Risk Factors for Alteration of the Cellular-arterial Gradient of CO2

DELTA-CAPNO: Identification of Risk Factors for Alteration of the Cellular-arterial Gradient of CO2 in Pre-hospital Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Monocentric, prospective, observational and descriptive study on the evaluation of risk factors for alteration of the alveoarterial gradient of CO2 in pre-hospital patients, intubated and then ventilated in an invasive manner; and their impact on intra-arterial fatehospital.

Conditions

Timeline

Start date
2020-06-03
Primary completion
2021-04-01
Completion
2021-06-01
First posted
2020-07-28
Last updated
2020-12-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04489615. Inclusion in this directory is not an endorsement.

Identification of Risk Factors for Alteration of the Cellular-arterial Gradient of CO2 (NCT04489615) · Clinical Trials Directory